We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+31.23%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$550M
AUM Growth
+$70.6M
Cap. Flow
-$37M
Cap. Flow %
-6.73%
Top 10 Hldgs %
19.32%
Holding
327
New
24
Increased
23
Reduced
152
Closed
29

Top Buys

Rank Stock Value
1
MIRM icon
Mirum Pharmaceuticals
MIRM
+$5.02M
2
GEV icon
GE Vernova
GEV
+$2.92M
3
COHU icon
Cohu
COHU
+$2.47M
4
MAMA icon
Mama's Creations
MAMA
+$2.39M
5
ORN icon
Orion Group Holdings
ORN
+$2.25M

Top Sells

Rank Stock Value
1
NUTX
Nutex Health
NUTX
+$7.08M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$6.56M
3
TVTX icon
Travere Therapeutics
TVTX
+$4.56M
4
GNRC icon
Generac Holdings
GNRC
+$3.88M
5
GWRE icon
Guidewire Software
GWRE
+$3.34M

Sector Composition

Rank Sector Weight
1 Industrials 30.33%
2 Technology 26.01%
3 Healthcare 18.4%
4 Financials 6.04%
5 Consumer Staples 4.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BP icon
276
BP
BP
$109B
$19.8K ﹤0.01%
662
– –
MU icon
277
Micron Technology
MU
$1.06T
$18.9K ﹤0.01%
153
– –
PPLI
278
People Inc
PPLI
$3.02B
$18.1K ﹤0.01%
486
-106
-18% -$3.83K
FIVE icon
279
Five Below
FIVE
$13.6B
$18K ﹤0.01%
137
– –
SLB icon
280
SLB Ltd
SLB
$76.9B
$17.4K ﹤0.01%
514
– –
APH icon
281
Amphenol
APH
$208B
$16.6K ﹤0.01%
168
– –
ANGI icon
282
Angi Inc
ANGI
$180M
$15K ﹤0.01%
+984
New +$14.2K
RRX icon
283
Regal Rexnord
RRX
$11.5B
$14.5K ﹤0.01%
100
– –
ADM icon
284
Archer Daniels Midland
ADM
$38.6B
$13.8K ﹤0.01%
262
– –
TER icon
285
Teradyne
TER
$63.9B
$13K ﹤0.01%
145
– –
TRIP icon
286
TripAdvisor
TRIP
$1.25B
$11.3K ﹤0.01%
867
– –
HP icon
287
Helmerich & Payne
HP
$4.26B
$11.1K ﹤0.01%
733
– –
GDXJ icon
288
VanEck Junior Gold Miners ETF
GDXJ
$8.35B
$10.5K ﹤0.01%
156
– –
FDX icon
289
FedEx
FDX
$78.4B
$10.2K ﹤0.01%
45
– –
SNY icon
290
Sanofi
SNY
$105B
$9.66K ﹤0.01%
200
– –
UNP icon
291
Union Pacific
UNP
$177B
$8.05K ﹤0.01%
35
– –
LYB icon
292
LyondellBasell Industries
LYB
$20.1B
$1.45K ﹤0.01%
25
– –
WTS icon
293
Watts Water Technologies
WTS
$12.8B
$1.23K ﹤0.01%
5
– –
XIFR
294
XPLR Infrastructure LP
XIFR
$1.08B
$631 ﹤0.01%
77
– –
OGN icon
295
Organon & Co
OGN
$3.6B
$106 ﹤0.01%
11
– –
ACIW icon
296
ACI Worldwide
ACIW
$5.36B
– –
-1,154
Closed -$63.1K
ATER icon
297
Aterian
ATER
$5.01M
– –
-28,648
Closed -$60.2K
BMRC icon
298
Bank of Marin Bancorp
BMRC
$469M
– –
-132,943
Closed -$2.93M
CSTE icon
299
Caesarstone
CSTE
$104M
– –
-113,320
Closed -$275K
EEFT icon
300
Euronet Worldwide
EEFT
$2.73B
– –
-225
Closed -$24K
9 10 11
12
13

Similar funds

BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
AP
Affinity Partners Sunny Isles Beach, Florida $635M AUM 43.43% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
WCM
Woodson Capital Management Greenwich, Connecticut $636M AUM 39.33% 1-Year Est. Return
FTC
Farmers Trust Company Youngstown, Ohio $637M AUM 23.14% 1-Year Est. Return

Essex Investment Management's Q2 2025 Portfolio in Review

As of Q2 2025, Essex Investment Management held 327 positions worth $550M, up 15% from $479M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Essex Investment Management withdrew a net $37M in Q2 2025, closing 29 positions and reducing 152 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $6.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Essex Investment Management opened a new position in Mirum Pharmaceuticals worth $5.74M.

  • Essex Investment Management's largest Q2 2025 buy was Mirum Pharmaceuticals: 112,731 shares worth $5.74M.
  • Essex Investment Management added most to GE Vernova in Q2 2025, an estimated $2.92M increase.
  • Essex Investment Management's biggest Q2 2025 reduction was Nutex Health, cutting an estimated $7.08M.
  • Essex Investment Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $6.56M.
  • Essex Investment Management's ten largest holdings make up 19% of its $550M portfolio in Q2 2025.
  • Essex Investment Management opened 24 new positions and closed 29 in Q2 2025.
  • Essex Investment Management's portfolio value rose 15% quarter-over-quarter to $550M.

Based on Essex Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.